Funding a founder-led business is a decision about control as much as cash. Senior debt is the cheapest capital in ownership terms and the least forgiving in cash terms: it wants predictable earnings and security, and it takes the business back if those fail. Mezzanine sits between the two, costing more than senior debt and diluting less than equity. Growth equity buys a minority stake and brings a governance layer with it. Patient capital accepts a longer horizon and usually asks for a real say in how the company is run. A management buyout moves ownership to the people already running the business, normally financed by a mix of the structures above. Buy-and-build uses one company as a platform to acquire others, and it changes the operating problem before it changes the balance sheet. The structure that fits is the one that matches your cash profile and your appetite for oversight, not the one with the best headline price.
Which funding structure fits a founder-led business?
Most founders arrive at this decision holding two options: borrow, or sell a slice. There are more than two, and they behave differently under stress. The table maps each structure to the moment it suits and to what it costs in control, which is where the real price sits.
| Structure | The moment it fits | What it costs in control | Where to read more |
|---|---|---|---|
| Senior debt | Predictable cash generation, an asset base, a defined use of funds | No ownership given up; covenants, security and reporting constrain the next decision | Start with what investors look at before you ask anyone to price your risk. |
| Mezzanine | Earnings are strong but not strong enough to carry more senior debt, and dilution is unwelcome | Ranks behind senior lenders, prices accordingly, and often carries an equity feature | Read how mezzanine finance sits between the two layers. |
| Growth equity | A proven model that needs capital to widen, not to prove itself | A minority shareholder, a board seat, information rights and a shared view on exit | See venture capital versus private equity for how the two mandates differ. |
| Patient capital | Value takes years to compound and quarterly pressure would distort the plan | A long-term partner with a real say, and less room to change direction quietly | Compare growth capital versus patient capital before you choose a horizon. |
| Management buyout | The founder wants out or wants less, and the team already runs the business | Ownership moves to management, funded by layers that each attach their own conditions | Read how a management buyout is structured. |
| Buy-and-build | One business is stable enough to absorb another without breaking | Acquisition facilities, integration commitments and a plan you are now held to | Read what changes after the money lands. |
Senior debt and mezzanine are both promises to pay. They leave the share register alone and take their security in cash flow and covenants instead. That suits a business whose revenue is repeatable and whose margin survives a bad quarter. It suits nothing else, because the repayment schedule does not care whether the market moved.
Growth equity and patient capital are both promises to share. Neither takes monthly cash out of the business, and both take a seat at the table in exchange. The difference between them is the clock: one expects a defined path to a liquidity event, the other accepts that compounding takes time and prices the wait into the relationship.
A management buyout and a buy-and-build are not funding structures in the same sense. They are transactions that get financed by the four above, usually in combination. Treating them as alternatives to debt or equity is the fastest way to end up with a deal that funds correctly and operates badly.
If you would rather test a structure against your numbers than against a template, that is the conversation we have.
When is debt the right answer and when is it not?
Debt is the right answer when the business already generates the cash to service it and the money buys something with a known return: a machine, a contract, working capital for orders you can see. In that case borrowing is the cheapest capital available, because you keep every share you own and pay for the privilege in interest and discipline.
It is the wrong answer when the money is buying a hypothesis. Development spend, a new market, a rebuild of the operating model — these produce returns on a timetable nobody can promise, and a repayment schedule will strangle them halfway through. Covenants compound the problem: they are usually breached in the quarter you most need flexibility.
One point of scope, because it catches founders on this side of the water. The Isle of Man is a self-governing Crown Dependency, not part of the United Kingdom, with its own company law. UK business-support schemes — the British Business Bank, Start Up Loans, Innovate UK, Growth Hubs — generally do not extend to the Island; support here runs through the Department for Enterprise. Where a funding decision turns on law or tax, take it to your own adviser rather than a blog.
What do you give up with equity, in practice?
Dilution is the part founders see and the smallest part of what changes. Selling a minority stake brings a shareholders' agreement, reserved matters, information rights and a board that now has to be informed before decisions rather than after them. Things you used to decide over a weekend become things you schedule.
The second cost is alignment on exit. An equity investor has a return to deliver and a horizon in which to deliver it, so the question of what happens to the company in the years ahead stops being yours alone. That is not automatically bad. It is the reason a growth round and a patient capital relationship are different products with similar paperwork.
The third cost is honesty. Equity money buys the right to ask uncomfortable questions in a room you used to control. Founders who resent that tend to have picked the wrong investor; founders who use it tend to find their own numbers get better. In our view, the discomfort is the product.
How do these structures stack on each other?
Real deals rarely use one instrument. A management buyout typically layers senior debt against the assets, mezzanine to bridge the gap the senior lender will not cover, and equity — from the management team, an investor, or both — to complete the price. A buy-and-build adds an acquisition facility on top and commits the platform to a pace of integration it has never run at.
The thing to watch is that each layer brings its own conditions, and conditions do not cancel each other out. They accumulate. Senior covenants, mezzanine terms and a shareholders' agreement can each be reasonable on their own and, stacked, leave you needing three consents to do something you would once have done that afternoon.
That is the argument for deciding the operating structure before the capital structure. If reporting, finance and decision rights are already sound, a stacked deal is administration. If they are not, the stack exposes every weakness at once, at the worst moment.
What changes after the money lands?
The reporting cadence changes first, and most teams underestimate how much capacity monthly management information consumes when the finance function was built for a quarterly rhythm. The second change is that the plan becomes a commitment. What was a view of the year is now the thing you are measured against.
The third is operational, and it is where capital alone usually disappoints. Money does not build a finance function, fix compliance or integrate an acquired team. For a recruitment startup, we ran marketing, IT, compliance and finance across roughly a twelve-month runway — not as advice delivered to a founder, but as the work itself. That is the difference between an investor who funds a plan and a partner who is inside its execution.
Scaling is re-architecture rather than expansion, which is why the structure question deserves more attention than the amount; capital arrives into whatever operating model it finds and accelerates it in either direction.
If you are weighing two structures and the numbers point in different directions, bring us the decision.
Frequently asked questions
Is debt always cheaper than equity?
In ownership terms, yes: you keep your shares. In risk terms, no. Debt must be serviced whatever the month looks like, and it is secured, so a bad run costs you more than dilution would have. Cheap capital against unpredictable cash flow is not cheap.
Can a founder keep control after a growth equity round?
Control of the share register and control of decisions are separate questions. A minority investor may hold a small percentage and still hold reserved matters that require their consent. Read the shareholders' agreement more carefully than the valuation, and have your own adviser read it too.
Do UK funding schemes apply to an Isle of Man business?
Generally not. The Island is a self-governing Crown Dependency with its own legislation, and UK schemes such as the British Business Bank, Start Up Loans, Innovate UK and Growth Hubs are UK bodies. Business support on the Island runs through the Department for Enterprise.
What is the difference between an operating partner and a fractional COO?
An operating partner sits on the investor's side, arrives with the capital and is aligned through carried interest. A fractional COO is your hire, part-time, and owns and runs operations day to day — fractional describes the commitment, not the seniority. The two solve different problems.
Choose the structure your next stage can actually carry, then negotiate the price.
